Reece has been consistently rated as a leading ‘Capital Markets’ and ‘Corporate M&A’ lawyer by Asia Pacific Legal 500, providing ‘high quality advice, and being committed to the client’s needs’. Since 2017, Reece has been ranked in the Corporate Law category of Best Lawyers Australia.
His work has covered the life sciences, technology, telecommunications, travel, food and agribusiness, engineering and resources sectors. His clients include multinational corporations, ASX listed companies and early-stage companies with high growth potential.
The FTX collapse: The governance red flags top-tier investors ignored
Post-IPO lock-up: Protecting Australian investors at the risk of global competitiveness
Numerous including Wagners, Over the Wire, Other Levels, Anatara Lifesciences, Corporate Travel Management, Seymour Whyte, Ausenco, Genera Biosystems, Invion, Provet and GBST.
Numerous including Ausenco, Corporate Travel Management, Carbon Energy, Viralytics, Tissue Therapies, Invion, Imugene, Lindsay Australia and Prescient Therapeutics.
For a number of leading clients throughout Australia and cross-border, including expansion of Corporate Travel Management and Technology One.
Advising on the $225 million takeover of Cephalon, Inc.
Advising on the $93.2 million acquisition under scheme of arrangements by Fortune 500 company, Henry Schein, Inc.
Advising a range of specialised funds and investee companies with a focus on technology and creative industries.
Australian due diligence for Archer Daniels Midland’s US $1.2 billion sale of its cocoa business and Ontario Teachers Pension Plan’s US $1billion acquisition of Constellation Brands’ Canadian wine business.
Advising on the $502 million acquisition of Viralytics Limited by Merck by scheme of arrangement.
Brisbane
Level 11, 66 Eagle Street
Brisbane QLD 4000
Tel +61 7 3233 8888
Sydney
Level 32, 25 Martin Place
Sydney NSW 2000
Tel +61 2 8241 5600
Canberra
Level 9, 2 Phillip Law Street
Canberra ACT 2601
Tel +61 2 8241 5600
